Would you recommend elective pelvic node XRT in a high risk prostate patient who has vascular disease?

Community
Company
News
Contact Us
Sign in

Topics: Radiation Oncology • Genitourinary Cancers

Assume patient has history of aortofemoral bypass. Is there any evidence that elective nodal radiation increases morbidity or mortality due to vascular disease?

Related Questions

How do you manage favorable intermediate risk prostate cancer patients that have a PIRADS 5 lesion that was most-likely missed in the template biopsy?

How would you treat a patient with retroperitoneal lymphadenopathy that has been biopsy proven metastatic seminoma, who is not a candidate for orchiectomy, RPLND, or systemic therapy?

Would you offer prostate SBRT to a patient on a TKI?

How does RTOG 0815 change your recommendation for ST-ADT for men getting XRT for favorable intermediate risk prostate ca?

How do you approach a patient after chemoradiation to the bladder with persistently positive urine cytology but negative endoscopic or radiographic workup?

Do you ever initiate on degarelix and then switch to leuprolide for patients with prostate cancer and cardiac risk factors receiving ADT?

Would you recommend prostate re-irradiation using SBRT?

In patients who have residual bladder tumors after maximal TURBT, would you boost the GTV above typical doses, 55 Gy/20 fractions or 64 Gy/32 fractions, assuming you can meet constraint?

For patients with metastatic RCC and gross hematuria from the primary tumor, what palliative radiation regimen would you recommend to help control the bleeding?

Would you offer prostate SBRT to a patient who cannot have an MRI?